Clinical Trial Update: Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

View source ↗

Summary

A completed clinical trial evaluating serum FT4 and FT3 measurements in subjects treated with eslicarbazepine acetate (ESL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Epilepsy | Status: COMPLETED | Results posted: 2018-02-05